J. Siegel

The Investigative Process

J. Siegel, Carol Wierwille, B. O'neal, 2007 .

Stabilizers Used in Intravenous Immunoglobulin Products

H. Ochs, J. Siegel, Helene E. Young, 2010 .

Use and prescribing patterns for erythropoiesis-stimulating agents in inpatient and outpatient hospital settings.

Philip E. Johnson, J. Siegel, D. Brophy, 2008, American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists.

Impact of the Medicare Prescription Drug Improvement and Modernization Act on the management of colorectal cancer.

J. Siegel, 2006, American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists.

Safety considerations in IGIV utilization.

J. Siegel, 2006, International immunopharmacology.

Preventability and severity assessment in reporting adverse drug reactions.

P. Schneider, J. Siegel, S. Hartwig, 1992, American journal of hospital pharmacy.

The Product: All Intravenous Immunoglobulins Are Not Equivalent

J. Siegel, 2005, Pharmacotherapy.

Diversion in the Operating Room

J. Siegel, B. O'neal, Kristen Bass, 2007 .

Prevention of Controlled Substance Diversion - Use of Diversion Detection Software

J. Siegel, B. O'neal, 2007 .

Code N: Multidisciplinary Approach to Proactive Drug Diversion Prevention

J. Siegel, B. O'neal, 2007 .